Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Peripheral Blood CD34 Stem Cell Implantation in Chronic Stroke
NCT00950521Phase 2Completed
- Sponsor
- China Medical University Hospital
- Start
- Jun 2009
- Primary completion
- Dec 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous peripheral blood CD34+ stem cells in stroke and middle cerebral artery infarction (2 arms), sponsored by China Medical University Hospital. Primary endpoint: National Institutes of Health Stroke Scale at 12 months. Started Jun 2009; status: completed.
02
Drugs
autologous peripheral blood CD34+ stem cells
03
Conditions
strokemiddle cerebral artery infarction
Beyond the preview
Go deeper on NCT00950521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950521.